I

ILiAD Biotechnologies, LLC

15 employees

ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Pharmaceutical
Clinical Trials
Infectious Diseases and Pediatrics

Date founded

2012

Funding rounds raised

Total raised

$20M

from 3 investors over 3 rounds

I

ILiAD Biotechnologies, LLC raised $1M on April 26, 2022

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

I

ILiAD Biotechnologies, LLC raised $20M on December 19, 2018

Investors: Network 1 Security Solutions Inc (NSSI)

I

ILiAD Biotechnologies, LLC raised undisclosed on January 1, 2014

Investors: Endo Investors

FAQ